Commercial DynamicsThere is still a level of uncertainty around commercial dynamics for a gene therapy.
Price TargetPrice target reduced to $16 from $17, reflecting updated R&D expenses for ongoing pivotal trials.
Revenue RisksRisks include failure of developmental candidates to achieve peak commercial revenue estimates due to market size, penetration rates, and/or pricing.